ClinConnect ClinConnect Logo
Search / Trial NCT00551174

A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment

Launched by HOFFMANN-LA ROCHE · Oct 29, 2007

Trial Information

Current as of July 22, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Successful completion of Bonviva study BM16550 (NCT00048074), with at least 75% compliance
  • Ambulatory
  • Exclusion Criteria:
  • Patients who completed the Bonviva study BM16550 (NCT00048074) \>3 months before the planned start date for this study
  • Malignant disease diagnosed since inclusion into previous study
  • Treatment with drugs affecting bone metabolism since inclusion into previous study

About Hoffmann La Roche

Hoffmann-La Roche, commonly known as Roche, is a global leader in biotechnology and pharmaceuticals, committed to advancing healthcare through innovative research and development. With a strong focus on oncology, immunology, infectious diseases, and central nervous system disorders, Roche leverages cutting-edge science to deliver transformative therapies and diagnostics. The company is dedicated to improving patient outcomes by conducting rigorous clinical trials and collaborating with healthcare professionals and organizations worldwide. Roche's unwavering commitment to precision medicine and personalized healthcare positions it at the forefront of the industry, driving progress in the quest for effective treatments and improved patient care.

Locations

Pretoria, , South Africa

Berlin, , Germany

Madison, Wisconsin, United States

Madrid, , Spain

Gainesville, Florida, United States

Omaha, Nebraska, United States

Liege, , Belgium

Aalborg, , Denmark

Ballerup, , Denmark

Vejle, , Denmark

Budapest, , Hungary

Siena, , Italy

Valeggio Sul Mincio, , Italy

Haugesund, , Norway

Oslo, , Norway

Stavanger, , Norway

Cape Town, , South Africa

St Louis, Missouri, United States

Fargo, North Dakota, United States

St. Leonards, , Australia

Sydney, , Australia

Bruxelles, , Belgium

Plzen, , Czech Republic

Praha, , Czech Republic

København, , Denmark

århus, , Denmark

Arenzano, , Italy

Mexico City, , Mexico

Monterrey, , Mexico

Grudziadz, , Poland

Krakow, , Poland

Sommerset West, , South Africa

Bismarck, North Dakota, United States

Lyon, , France

Orleans, , France

Omaha, Nebraska, United States

Hamburg, , Germany

Aberdeen, , United Kingdom

Essen, , Germany

Patients applied

0 patients applied

Trial Officials

Clinical Trials

Study Director

Hoffmann-La Roche

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials